- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
DBC2 antibody recognizes Deleted in breast cancer gene 2, a tumor suppressor protein encoded by the RHOBTB2 gene and commonly referred to as DBC2 in the literature. Deleted in breast cancer gene 2 belongs to the RhoBTB subfamily of atypical Rho GTPase-related proteins and is primarily localized to the cytoplasm. Unlike classical Rho GTPases, DBC2 does not function as a molecular switch but instead acts as an adaptor protein involved in regulation of cell cycle progression, intracellular trafficking, and protein turnover. DBC2 Antibody is used in research settings to study tumor suppressor signaling and dysregulated cellular pathways associated with malignant transformation.
Deleted in breast cancer gene 2 was originally identified through recurrent chromosomal deletions and reduced expression in breast carcinoma, which led to its designation as a tumor suppressor. Subsequent studies have demonstrated altered RHOBTB2 expression across multiple cancer types, with loss or downregulation associated with increased cell proliferation, impaired apoptotic responses, and enhanced migratory behavior. DBC2 Antibody enables evaluation of these expression changes and supports investigation of cancer-associated signaling pathways and tumor progression mechanisms.
At the molecular level, Deleted in breast cancer gene 2 contains BTB domains that mediate interactions with Cullin 3-based E3 ubiquitin ligase complexes. Through these interactions, DBC2 contributes to ubiquitin-dependent degradation of specific protein substrates involved in cell division and stress response pathways. RHOBTB2 Antibody tools therefore support studies focused on ubiquitin signaling, proteostasis regulation, and intracellular quality control mechanisms in both normal and disease contexts.
Beyond oncology, RHOBTB2 has also been implicated in neurological and developmental processes, broadening interest in Deleted in breast cancer gene 2 beyond cancer biology alone. DBC2 Antibody allows visualization and assessment of cytoplasmic RHOBTB2 expression in experimental systems, supporting research into tissue-specific roles and disease-associated alterations. Clone DBC2/3362 is designed to recognize Deleted in breast cancer gene 2 and may be applied to studies of tumor suppression, intracellular signaling, and ubiquitin-mediated regulatory pathways.
Optimal dilution of the DBC2 antibody should be determined by the researcher.
A portion of amino acids 554-604 from the human protein was used as the immunogen for the DBC2 antibody.
Store the DBC2 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.